BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 28367075)

  • 1. Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression.
    Ratovitski EA
    Curr Genomics; 2017 Apr; 18(2):175-205. PubMed ID: 28367075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites.
    Attar R; Tabassum S; Fayyaz S; Ahmad MS; Nogueira DR; Yaylim I; Timirci-Kahraman O; Kucukhuseyin O; Cacina C; Farooqi AA; Ismail M
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):62-8. PubMed ID: 26518897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions.
    Jasek K; Kubatka P; Samec M; Liskova A; Smejkal K; Vybohova D; Bugos O; Biskupska-Bodova K; Bielik T; Zubor P; Danko J; Adamkov M; Kwon TK; Büsselberg D
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31323834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
    Gerhauser C
    Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer epigenetics: Past, present and future.
    Lee JE; Kim MY
    Semin Cancer Biol; 2022 Aug; 83():4-14. PubMed ID: 33798724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents.
    Wang Y; Li Y; Liu X; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):506-18. PubMed ID: 23597195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms.
    Shoaib S; Ansari MA; Ghazwani M; Hani U; Jamous YF; Alali Z; Wahab S; Ahmad W; Weir SA; Alomary MN; Yusuf N; Islam N
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of epigenetic therapies in colorectal cancer.
    Baretti M; Azad NS
    Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Compounds: Role in Reversal of Epigenetic Changes.
    Aggarwal R; Jha M; Shrivastava A; Jha AK
    Biochemistry (Mosc); 2015 Aug; 80(8):972-89. PubMed ID: 26547065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer.
    Humphries B; Wang Z; Yang C
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulators of Mesenchymal Stem/Stromal Cell Lineage Determination.
    Cakouros D; Gronthos S
    Curr Osteoporos Rep; 2020 Oct; 18(5):597-605. PubMed ID: 32794139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary components as epigenetic-regulating agents against cancer.
    Chang LC; Yu YL
    Biomedicine (Taipei); 2016 Mar; 6(1):2. PubMed ID: 26872811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and therapeutic profiles of DNA methylation alterations in cancer; an overview of changes in chromatin arrangement and alterations in histone surfaces.
    Norollahi SE; Vahidi S; Shams S; Keymoradzdeh A; Soleymanpour A; Solymanmanesh N; Mirzajani E; Jamkhaneh VB; Samadani AA
    Horm Mol Biol Clin Investig; 2023 Sep; 44(3):337-356. PubMed ID: 36799246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Epigenetics in Cancer.
    Bennett RL; Licht JD
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic effects of nano-sized materials.
    Stoccoro A; Karlsson HL; Coppedè F; Migliore L
    Toxicology; 2013 Nov; 313(1):3-14. PubMed ID: 23238276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.